HSDT Helius Medical Technologies
- 4.5000
- +0.0600+1.35%
Helius Medical Technologies News
Helius Medical Technologies Expands Stroke Clinical Program With Participation Of Shepherd Center
-- Helius Medical and Shepherd Center partner on a study that aims at rehabilitating walking mobility in people recovering from stroke ---- Shepherd Center, a top neurorehabilitation hospital, is the
Helius Medical Technologies, Inc. Expands Stroke Clinical Program With Participation of Shepherd Center
Helius Medical and Shepherd Center partner on a study that aims at rehabilitating walking mobility in people recovering from stroke.
Helius Medical Files to Sell Class A Common Stock, Warrants
12 Health Care Stocks Moving In Friday's Pre-Market Session
GainersProtara Therapeutics (NASDAQ:TARA) stock increased by 40.3% to $5.64 during Friday's pre-market session. The market value of their outstanding shares is at $64.4 million. Candel Therapeutics (N
EC, ABAT and BORR Among Pre-market Losers
12 Health Care Stocks Moving In Thursday's Pre-Market Session
GainersTevogen Bio Holdings (NASDAQ:TVGN) stock rose 85.5% to $4.86 during Thursday's pre-market session. The market value of their outstanding shares is at $800.0 million. Candel Therapeutics (NASDAQ
12 Health Care Stocks Moving In Wednesday's After-Market Session
GainersAesthetic Medical Intl (NASDAQ:AIH) shares rose 14.0% to $0.52 during Wednesday's after-market session. The company's market cap stands at $24.9 million. Kineta (NASDAQ:KA) shares rose 8.46% to
Helius Medical Shares Rise 10% After Partnership With Lovell Govt Services
By Chris Wack Helius Medical Technologies shares were up 10% to $6.25 after the company said it has partnered with Lovell Government Services, an SBA-certified Service Disabled Veteran Owned Small Bu
FibroGen, Acorda Therapeutics, Enveric Biosciences Among Healthcare Movers
Notable Partnership Boosts Helius Medical (HSDT) Stock
Helius Medical Technologies, Inc. (NASDAQ: HSDT) is witnessing a notable surge of 22.83% during the pre-market trading session, currently valued at $6.95 per share. This positive momentum in HSDT shares can be directly attributed to the recent announcement of a strategic partnership. Today, Helius Medical (HSDT) and Lovell Government Services announced their partnership. Through this ...
Market-Moving News for April 3rd
ABIO: 165% | ARCA Biopharma shares are trading higher after the company and Oruka Therapeutics announced a merger agreement.LGVC: 193% | LAMF Global Ventures Corp. I Shareholders Approve Previously An
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
GainersARCA biopharma (NASDAQ:ABIO) stock moved upwards by 124.6% to $3.84 during Wednesday's pre-market session. The market value of their outstanding shares is at $55.6 million. Kintara Therapeutics
Helius Medical Technologies, Inc. Announces Partnership With Lovell Government Services to Expand Reach of PoNS Therapy
Helius Medical Technologies, Inc. (NASDAQ:HSDT) ("Helius" or the "Company"), a neurotech company focused on delivering a novel therapeutic neuromodulation approach for balance and gait deficits, today
Helius Medical Technologies (HSDT) Gets a Buy From Maxim Group
Helius Medical Technologies, Inc. (NASDAQ:HSDT) Q4 2023 Earnings Call Transcript
Earnings Call Summary | Helius Medical Technologies(HSDT.US) Q4 2023 Earnings Conference
The following is a summary of the Helius Medical Technologies, Inc. (HSDT) Q4 2023 Earnings Call Transcript:Financial Performance:Helius Medical Technologies reported a Q4 2023 revenue of $134,000, a
Helius Medical Tech Q4 2023 GAAP EPS $(1.47) Beats $(3.77) Estimate, Sales $134.000K Miss $246.333K Estimate
Helius Medical Tech (NASDAQ:HSDT) reported quarterly losses of $(1.47) per share which beat the analyst consensus estimate of $(3.77) by 61.01 percent. The company reported quarterly sales of $134.00
Recap: Helius Medical Tech Q4 Earnings
Helius Medical Tech (NASDAQ:HSDT) reported its Q4 earnings results on Thursday, March 28, 2024 at 04:05 PM.Here's what investors need to know about the announcement.EarningsHelius Medical Tech beat es
Helius Medical Tech 4Q Loss/Shr $1.47 >HSDT
Helius Medical Tech 4Q Loss/Shr $1.47 >HSDT
Helius Medical Technologies GAAP EPS of -$1.47 Beats by $2.30, Revenue of $0.13M Misses by $0.12M
Analysis
Price Target
No Data
